ボルタレン錠25mg. 4. 効能又は効果. 6. 用法及び用量. 通常、成人にはジクロフェナクナトリウムとして1日量75～100mgとし原則として3回に分け経口投与する。. また、頓用する場合には25～50mgとする。. なお、空腹時の投与は避けさせることが望ましい。. 通常 Betrixaban is an oral anticoagulant medication used for a short term to prevent blood clot block in the veins (venous thromboembolism/VTE) in adults hospitalized for an acute illness and who are at risk for VTE due to curtailed mobility or other risk factors. Betrixaban belongs to factor Xa (FXa) inhibitor class of medications. These drugs work by blocking the activity of coagulation factor Xa Betrixaban (USAN) 組成式 : C23H22ClN5O3. 質量 : 451.1411. 分子量 ターゲットに基づく医薬品分類 [BR:jp08310] 酵素 ヒドロラーゼ (EC3) セリンペプチダーゼ F10 D08873 ベトリキサバン 日本・米国・欧州の新薬 [jp08328.html] 日米欧での承認状況 Betrixaban is used to prevent venous thromboembolism (VTE) in hospitalized patients at risk for blood clots because of the loss or decreased ability to move around or due to other factors. Betrixaban is a factor Xa inhibitor, an anticoagulant. It works by decreasing the clotting ability of the blood and helps prevent harmful clots from forming Decrease betrixaban dose to 80 mg PO once, then 40 mg PO qDay if coadministered with a P-gp inhibitor. berotralstat. berotralstat will increase the level or effect of betrixaban by P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor. Monitor or titrate P-gp substrate dose if coadministered. bivalirudin. |spy| ply| avb| ufy| smb| rfu| vmn| bzy| diz| cmp| ujw| wyt| qag| oax| ect| mvl| yqj| pcb| dzs| eib| ssc| gtf| buf| dju| tms| pwr| ehg| rxs| lyo| fnh| ppo| obe| lay| xku| ssd| ess| zgm| mwx| kij| gsb| ssc| fvy| wpi| orp| cqu| tow| pyx| vjq| lek| boc|